Spyre Therapeutics, Inc. · GETTEX:3920
Spyre Therapeutics, Inc. shareholders
As of Sep 30, 2026, 273 institutions reported holding Spyre Therapeutics, Inc. Largest: Fidelity, Vanguard and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Spyre Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 13.5M | +470K | Nov 10, 2026 | |
| Vanguard | 8.53M | +2.1M | Nov 16, 2026 | |
| BlackRock | 6.78M | +273K | Nov 13, 2026 | |
| Paradigm Biocapital Advisors LP | 4.46M | +617K | Nov 16, 2026 | |
| Rtw Investments, LP | 3.69M | −560K | Nov 16, 2026 | |
| State Street | 3.53M | +476K | Nov 12, 2026 | |
| T. Rowe Price | 3.5M | +543K | Nov 16, 2026 | |
| Perceptive Advisors LLC | 3.28M | −1.04M | Nov 16, 2026 | |
| Capital Group | 2.99M | −276K | Nov 12, 2026 | |
| Janus Henderson | 2.89M | first report | Nov 16, 2026 |